Supplier of key reagents for drug development.

+86-15801534258
info@nebulabio.cn
Product Name NebuSelect™ Recombinant Cynomolgus GPC3/Glypican 3, His-tag
Catalog Number NBL-242564
Alias/Synonyms GPC3/Glypican 3; GPC3; DGSX; Glypican 3; GTR2-2; MXR7; OCI5; OCI-5; SGB; SGBS; SGBS1SDYS; SDYS; SGBS1
Appearance see COA
Molecule Weight
CAS N/A
Solubility Water Soluble
Storage Short term 4℃; Long term -20℃.
Shelf Life 2 years
Additional info 1 XP_005594665.1
Additional info 2
Catalog Numbe Size Price Inventory Level  
NBL-242564-100ug 100ug Inquire Inquire
NBL-242564-1mg 1mg Inquire Inquire
NBL-242564-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Cynomolgus GPC3/Glypican 3, His-tag


Catalog#:

NBL-242564


Description:

NebuSelect™ Recombinant Cynomolgus GPC3/Glypican 3, His-tag(Cat#NBL-242564) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln25-His559.


Species:

Cynomolgus


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 61.8 kDa. Due to glycosylation, the protein migrates to 42 kDa, 70-135 kDa based on Bis-Tris PAGE result.


Target Name:

GPC3/Glypican 3; GPC3; DGSX; Glypican 3; GTR2-2; MXR7; OCI5; OCI-5; SGB; SGBS; SGBS1SDYS; SDYS; SGBS1


Target Information:

Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed.


Amino Acid Sequence: 


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

Top-selling Items